Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07535463) titled 'A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer' on April 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Non-Small Cell Lung Cancer
Intervention:
Drug: Ivonescimab
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: April 10, 2026
Target Sample Size: 53
Countries of Recruitment:
United States
To know more, visit https://clinicaltri...